Dynamic interactions between host and pathogen during acute urinary tract infections
- PMID: 11378051
- DOI: 10.1016/s0090-4295(01)01130-x
Dynamic interactions between host and pathogen during acute urinary tract infections
Abstract
Urinary tract infections (UTIs) have traditionally been viewed as acute and often self-limiting infections caused predominantly by noninvasive Escherichia coli. However, this concept has been challenged by recent findings demonstrating that an acute bladder infection results from a complex series of host-pathogen interactions that can lead to bacterial invasion and persistence and that ultimately can determine the course of the infectious disease. The ability of E. coli to gain a foothold in the bladder is greatly facilitated by type 1 pilus-mediated attachment to and invasion of bladder epithelial cells. Invasion allows uropathogenic strains of E. coli to exploit the intracellular environment by replicating within these epithelial cells while evading a multitude of host defenses. An intracellular location also provides them a safe haven from many common antibiotic therapies. However, attachment and invasion also activates a cascade of innate host defenses, leading to the death and exfoliation of bladder cells and the production of inflammatory mediators. The ability of uropathogenic E. coli to flux out of cells and colonize surrounding cells provides them a mechanism to subvert these defense mechanisms and persist in the bladder epithelium for weeks following the acute infection. The persistence of E. coli in bladder tissue may be relevant to more chronic diseases of the urinary tract such as recurrent UTIs and interstitial cystitis.
Similar articles
-
Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8829-35. doi: 10.1073/pnas.97.16.8829. Proc Natl Acad Sci U S A. 2000. PMID: 10922042 Free PMC article. Review.
-
Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.Infect Immun. 2001 Jul;69(7):4572-9. doi: 10.1128/IAI.69.7.4572-4579.2001. Infect Immun. 2001. PMID: 11402001 Free PMC article.
-
Intracellular bacterial biofilm-like pods in urinary tract infections.Science. 2003 Jul 4;301(5629):105-7. doi: 10.1126/science.1084550. Science. 2003. PMID: 12843396
-
Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E871-80. doi: 10.1073/pnas.1500374112. Epub 2015 Feb 9. Proc Natl Acad Sci U S A. 2015. PMID: 25675528 Free PMC article.
-
Host subversion by formation of intracellular bacterial communities in the urinary tract.Microbes Infect. 2004 Oct;6(12):1094-101. doi: 10.1016/j.micinf.2004.05.023. Microbes Infect. 2004. PMID: 15380779 Review.
Cited by
-
Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.Int Urogynecol J. 2012 Dec;23(12):1707-13. doi: 10.1007/s00192-012-1794-z. Epub 2012 May 22. Int Urogynecol J. 2012. PMID: 22614285 Clinical Trial.
-
Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections.Infect Immun. 2010 Oct;78(10):4166-75. doi: 10.1128/IAI.00711-10. Epub 2010 Aug 9. Infect Immun. 2010. PMID: 20696830 Free PMC article.
-
Intravesical instillations for the treatment of refractory recurrent urinary tract infections.Ther Adv Urol. 2018 Feb 18;10(5):157-163. doi: 10.1177/1756287218757655. eCollection 2018 May. Ther Adv Urol. 2018. PMID: 29623107 Free PMC article.
-
Viable but nonculturable bacteria are present in mouse and human urine specimens.J Clin Microbiol. 2004 Feb;42(2):753-8. doi: 10.1128/JCM.42.2.753-758.2004. J Clin Microbiol. 2004. PMID: 14766848 Free PMC article.
-
Pathogenicity islands in bacterial pathogenesis.Clin Microbiol Rev. 2004 Jan;17(1):14-56. doi: 10.1128/CMR.17.1.14-56.2004. Clin Microbiol Rev. 2004. PMID: 14726454 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical